Nonlinear assessment of phenytoin bioavailability
- 1 August 1976
- journal article
- Published by Springer Science and Business Media LLC in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 4 (4), 327-336
- https://doi.org/10.1007/bf01063122
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Phenytoin: Pharmacokinetics and bioavailabilityClinical Pharmacology & Therapeutics, 1976
- Bioavailability and single‐dose pharmacokinetics of intramuscular phenytoinClinical Pharmacology & Therapeutics, 1975
- Diphenylhydantoin elimination kinetics in overdosed childrenClinical Pharmacology & Therapeutics, 1975
- Bioavailability of diphenylhydantoinClinical Pharmacology & Therapeutics, 1974
- PHENYTOIN DOSE ADJUSTMENT IN EPILEPTIC PATIENTSBritish Journal of Clinical Pharmacology, 1974
- Pharmacokinetics of single and multiple doses of phenytoin in manEuropean Journal of Clinical Pharmacology, 1974
- Bioavailability calculations for drugs showing simultaneous first-order and capacity-limited elimination kineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.1972
- Relationship between Dose and Plateau Levels of Drugs Eliminated by Parallel First-Order and Capacity-Limited KineticsJournal of Pharmaceutical Sciences, 1972
- Bioavailability, Clinical Effectiveness, and the Public InterestPharmacology, 1972